Drug Shortage Report for SANDOMIGRAN DS
| Report ID | 19806 |
| Drug Identification Number | 00511552 |
| Brand name | SANDOMIGRAN DS |
| Common or Proper name | Sandomigran |
| Company Name | PALADIN PHARMA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | PIZOTIFEN |
| Strength(s) | 1MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 tablets |
| ATC code | N02CX |
| ATC description | ANTIMIGRAINE PREPARATIONS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2019-04-24 |
| Actual start date | |
| Estimated end date | |
| Actual end date | 2019-04-24 |
| Shortage status | Resolved |
| Updated date | 2019-04-25 |
| Company comments | Avoided backorder |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 MONTREAL, QUEBEC CANADA H4M 2P2 |
| Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-08-18 | English | Compare |
| v2 | 2017-08-18 | French | Compare |
| v3 | 2019-04-24 | English | Compare |
| v4 | 2019-04-24 | French | Compare |
| v5 | 2019-04-25 | English | Compare |
Showing 1 to 5 of 5